Suppr超能文献

血液透析患者的幽门螺杆菌感染:对阿莫西林和克拉霉素的敏感性

Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin.

作者信息

Aydemir Selim, Boyacioglu Sedat, Gur Gurden, Demirbilek Muge, Can Fusun-Kamber, Korkmaz Murat, Yilmaz Ugur

机构信息

Department of Gastroenterology, Zonguldak Karaelmas University Faculty of Medicine, 67800, Zonguldak, Turkey.

出版信息

World J Gastroenterol. 2005 Feb 14;11(6):842-5. doi: 10.3748/wjg.v11.i6.842.

Abstract

AIM

To evaluate susceptibility of Helicobacter pylori to amoxicillin and clarithromycin in end-stage renal disease (ESRD) patients and non-uremic controls.

METHODS

The subjects with dyspeptic complaints were 33 ESRD patients and 46 age- and sex-matched non-uremic controls who exhibited H pylori on antral biopsy specimens. The two groups were age and sex matched. The H pylori strains' pattern of susceptibility to amoxicillin and clarithromycin was investigated with the agar dilution technique.

RESULTS

None of the H pylori strains from either group showed resistance to amoxicillin with the agar dilution method. Twelve (36.4%) of the ESRD group strains and 7 (15.2%) of the control group strains showed resistance to clarithromycin, and this difference was statistically significant (P<0.05).

CONCLUSION

Resistance to amoxicillin does not appear to be an important problem in H pylori-infected ESRD and non-uremic patients in our region. In contrast, the rates of resistance to clarithromycin are high, particularly in the ESRD population.

摘要

目的

评估终末期肾病(ESRD)患者和非尿毒症对照人群中幽门螺杆菌对阿莫西林和克拉霉素的敏感性。

方法

选取33例有消化不良症状的ESRD患者以及46例年龄和性别匹配、胃窦活检标本显示幽门螺杆菌阳性的非尿毒症对照者。两组在年龄和性别上相匹配。采用琼脂稀释法研究幽门螺杆菌菌株对阿莫西林和克拉霉素的敏感性模式。

结果

两组的幽门螺杆菌菌株经琼脂稀释法检测均未显示对阿莫西林耐药。ESRD组12株(36.4%)菌株和对照组7株(15.2%)菌株对克拉霉素耐药,差异有统计学意义(P<0.05)。

结论

在我们地区,幽门螺杆菌感染的ESRD患者和非尿毒症患者中,对阿莫西林耐药似乎不是一个重要问题。相比之下,对克拉霉素的耐药率较高,尤其是在ESRD人群中。

相似文献

1
Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin.
World J Gastroenterol. 2005 Feb 14;11(6):842-5. doi: 10.3748/wjg.v11.i6.842.
2
Eradication of Helicobacter pylori in hemodialysis patients.
Ren Fail. 2007;29(1):97-102. doi: 10.1080/08860220601039122.

引用本文的文献

2
Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Korean J Intern Med. 2019 Sep;34(5):1022-1029. doi: 10.3904/kjim.2018.054. Epub 2018 Jun 14.
3
Nutrition status and infection in patients receiving hemodialysis.
World J Gastroenterol. 2018 Apr 21;24(15):1591-1600. doi: 10.3748/wjg.v24.i15.1591.
4
Comparison of eradication regimens in patients with end stage renal disease.
Gastroenterol Hepatol Bed Bench. 2018 Winter;11(1):15-19.
6
Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens.
World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):127-36. doi: 10.4292/wjgpt.v6.i4.127.
9
Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.
Dig Dis Sci. 2014 Jun;59(6):1235-43. doi: 10.1007/s10620-014-3093-7. Epub 2014 Mar 6.
10
Helicobacter pylori Infection in Dialysis Patients: A Meta-Analysis.
Gastroenterol Res Pract. 2013;2013:785892. doi: 10.1155/2013/785892. Epub 2013 Nov 7.

本文引用的文献

1
Basis for the management of drug-resistant Helicobacter pylori infection.
Drugs. 2004;64(17):1893-904. doi: 10.2165/00003495-200464170-00003.
2
H pylori antibiotic resistance: prevalence, importance, and advances in testing.
Gut. 2004 Sep;53(9):1374-84. doi: 10.1136/gut.2003.022111.
3
Treatment of Helicobacter pylori infection.
Helicobacter. 2003;8 Suppl 1:53-60. doi: 10.1046/j.1523-5378.2003.00162.x.
5
Helicobacter pylori resistance to antibiotics: prevalence, mechanism, detection. What's new?
Can J Gastroenterol. 2003 Jun;17 Suppl B:49B-52B. doi: 10.1155/2003/704035.
6
The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.
Clin Microbiol Infect. 2002 Jul;8(7):388-96. doi: 10.1046/j.1469-0691.2002.00435.x.
7
Treatment of Helicobacter pylori infection. Indications and regimens: an update.
Dig Liver Dis. 2002 Jan;34(1):70-83. doi: 10.1016/s1590-8658(02)80062-7.
8
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Aliment Pharmacol Ther. 2002 Feb;16(2):167-80. doi: 10.1046/j.1365-2036.2002.01169.x.
9
Clarithromycin resistance in Helicobacter pylori and its clinical relevance.
World J Gastroenterol. 1999 Jun;5(3):263-266. doi: 10.3748/wjg.v5.i3.263.
10
European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori.
Eur J Clin Microbiol Infect Dis. 2001 Nov;20(11):820-3. doi: 10.1007/s100960100611.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验